GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ONCO · Mar 31, 2025

Onconetix, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001213900-25-053914General Corporate
Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1967.61% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-85.49% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

153.16% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

45.10% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

-12369.21% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

24.06% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

28.79% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History11 statesHistory building
Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/6 normalizedLevel 3Sep 30, 20250/6 normalizedLevel 3Dec 31, 20255/6 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-415.82%
Current
-1967.61%
Delta
-1551.79%
Growth Decreased
Previous
4217.31%
Current
-85.49%
Delta
-4302.80%
Inventory Pressure Increased
Previous
2.54%
Current
153.16%
Delta
150.62%
Margin Increased
Previous
41.80%
Current
45.10%
Delta
3.30%
Profitability Decreased
Previous
-2237.96%
Current
-12369.21%
Delta
-10131.25%
R And D Intensity Increased
Previous
6.12%
Current
24.06%
Delta
17.95%
Sbc Intensity Increased
Previous
17.38%
Current
28.79%
Delta
11.41%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · ONCO Fundamental State →Transitioned To · ONCO Fundamental State →Transitioned To · ONCO CASH_GENERATION_DECREASED →Transitioned To · ONCO GROWTH_DECREASED →Transitioned To · ONCO INVENTORY_PRESSURE_INCREASED →Transitioned To · ONCO MARGIN_INCREASED →Transitioned To · ONCO PROFITABILITY_DECREASED →Transitioned To · ONCO R_AND_D_INTENSITY_INCREASED →Transitioned To · ONCO SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.